Oxford Nanopore Technologies PLC (FRA:4R0)
€ 1.828 0 (0%) Market Cap: 1.48 Bil Enterprise Value: 1.22 Bil PE Ratio: 0 PB Ratio: 2.04 GF Score: 60/100

Oxford Nanopore Technologies PLC at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2023 / 08:55PM GMT
Release Date Price: €2.49 (-1.19%)
Tejas Savant
Morgan Stanley - Analyst

Hey, everyone. Good afternoon. My name is Tejas Savant. I'm the life science tools and diagnostics analyst here at Morgan Stanley. Before we get started for important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. If you have any questions, do reach out to your sales rep.

It's my pleasure this afternoon to host Oxford Nanopore and from the company, we have Gordon Sanghera, CEO. I know, Gordon, you want to make some opening remarks and introduce all the shiny toys you've brought with you. So take it away and then we'll get into Q&A.

Gordon Sanghera
Oxford Nanopore Technologies plc - CEO

Thanks, Tejas, and good afternoon, everybody. I might be the last person between you and the drink this evening. Hopefully, we can entertain you. I have here some toys, indeed. I have some sequences, actually, nanopore sequences, and I'll start with MinION, which Oxford Nanopore was formed in 2005 and was launched 10 years later, and it is a small portable

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot